社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
JJSLIN
IP属地：未知
+关注
帖子 · 9
帖子 · 9
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
JJSLIN
JJSLIN
·
2021-12-10
🚀🚀🚀
OCGN Stock Pops on Key FDA News. Here’s What to Know.
Biopharmaceutical company Ocugen(NASDAQ:OCGN) announced today that the U.S. Food and Drug Administra
OCGN Stock Pops on Key FDA News. Here’s What to Know.
看
1,890
回复
评论
点赞
4
编组 21备份 2
分享
举报
JJSLIN
JJSLIN
·
2021-12-01
$Histogenics(OCGN)$
🚀🚀🚀
看
2,087
回复
评论
点赞
5
编组 21备份 2
分享
举报
JJSLIN
JJSLIN
·
2021-11-29
End day become infinity 😀
@JuanJohnson：
Imagine now you would have to take 4 booster shots a year for life. Two for delta, two for omicron... And guess what? Next year you can add 4 more for another two variants that come along!Covaxin is good for all corona virus'$Histogenics(OCGN)$
Imagine now you would have to take 4 booster shots a year for life. Two for delta, two for omicron... And guess what? Next year you can add 4 more for another two variants that come along!Covaxin is good for all corona virus'$Histogenics(OCGN)$
看
2,158
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
JJSLIN
JJSLIN
·
2021-11-26
$Histogenics(OCGN)$
🚀🌙 💎🙌💎
看
1,949
回复
评论
点赞
2
编组 21备份 2
分享
举报
JJSLIN
JJSLIN
·
2021-11-08
$Histogenics(OCGN)$
Drop till I no feeling already.The best you can drop till $1 & let’s us ready for this roller coaster ride 🚀🚀🚀🚀🚀🚀
看
1,893
回复
1
点赞
3
编组 21备份 2
分享
举报
JJSLIN
JJSLIN
·
2021-05-24
$Grayscale Ethereum Trust(ETHE)$
Show Us Your Miracle
看
1,022
回复
2
点赞
7
编组 21备份 2
分享
举报
JJSLIN
JJSLIN
·
2021-04-30
Thanks
非常抱歉，此主贴已删除
看
1,827
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
JJSLIN
JJSLIN
·
2021-04-16
Let's earn more money
非常抱歉，此主贴已删除
看
1,924
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
JJSLIN
JJSLIN
·
2021-04-16
3.51
非常抱歉，此主贴已删除
看
952
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3581601922547073","uuid":"3581601922547073","gmtCreate":1618515768783,"gmtModify":1619755314114,"name":"JJSLIN","pinyin":"jjslin","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/bcd611a21236602bc49267fe3296259e","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":18,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.39%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":605921011,"gmtCreate":1639103141916,"gmtModify":1639103141916,"author":{"id":"3581601922547073","authorId":"3581601922547073","name":"JJSLIN","avatar":"https://static.tigerbbs.com/bcd611a21236602bc49267fe3296259e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581601922547073","authorIdStr":"3581601922547073"},"themes":[],"htmlText":"🚀🚀🚀","listText":"🚀🚀🚀","text":"🚀🚀🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605921011","repostId":"1186120067","repostType":2,"repost":{"id":"1186120067","kind":"news","pubTimestamp":1639102922,"share":"https://www.laohu8.com/m/news/1186120067?lang=&edition=full","pubTime":"2021-12-10 10:22","market":"us","language":"en","title":"OCGN Stock Pops on Key FDA News. Here’s What to Know.","url":"https://stock-news.laohu8.com/highlight/detail?id=1186120067","media":"InvestorPlace","summary":"Biopharmaceutical company Ocugen(NASDAQ:OCGN) announced today that the U.S. Food and Drug Administra","content":"<div>\n<p>Biopharmaceutical company Ocugen(NASDAQ:OCGN) announced today that the U.S. Food and Drug Administration (FDA) approved the company’s Investigational New Drug (IND) application for a human clinical ...</p>\n\n<a href=\"https://investorplace.com/2021/12/ocgn-stock-pops-on-key-fda-news-heres-what-to-know/\">Web Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OCGN Stock Pops on Key FDA News. Here’s What to Know.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOCGN Stock Pops on Key FDA News. Here’s What to Know.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 10:22 GMT+8 <a href=https://investorplace.com/2021/12/ocgn-stock-pops-on-key-fda-news-heres-what-to-know/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biopharmaceutical company Ocugen(NASDAQ:OCGN) announced today that the U.S. Food and Drug Administration (FDA) approved the company’s Investigational New Drug (IND) application for a human clinical ...</p>\n\n<a href=\"https://investorplace.com/2021/12/ocgn-stock-pops-on-key-fda-news-heres-what-to-know/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://investorplace.com/2021/12/ocgn-stock-pops-on-key-fda-news-heres-what-to-know/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186120067","content_text":"Biopharmaceutical company Ocugen(NASDAQ:OCGN) announced today that the U.S. Food and Drug Administration (FDA) approved the company’s Investigational New Drug (IND) application for a human clinical trial of OCU400. OCU400 is a gene-therapy candidate targeting several degenerative eye diseases that severely impair vision. Despite the news, OCGN stock is down 6.3% today as investors seem reluctant to buy into the struggling med-tech company.\nShankar Musunuri, chief executive and co-founder of Ocugen, commented on the significance of this recent development.\n\n“We are delighted to advance OCU400 into clinical trials, which exemplifies our goal of offering new options to people with genetic diseases where none currently exist. … We’re collaborating with leading centers in eye care and have been vital partners to getting our trial launched and receive patients. With this final decision by the FDA, we are embarking on a new pathway of care through this innovative gene therapy.”\n\nThe news comes as a welcome change of pace for the company. Ocugen is perhaps best known for its Covid-19 vaccine Covaxin, which largely lags behind the competition. On Nov. 30, the FDA issued a hold on an approval application for late-stage clinical testing of its vaccine.\nOcugen represents just the North American side of the vaccine’s distribution. Meanwhile, Bharat Biotech, co-developer of the vaccine, has earned approval for use in 17 countries, including the company’s native India. This stands in stark contrast to Ocugen, who many investors believe is too little too late. Ocugen has come under fire for attempting to penetrate largely saturated Western markets as it pertains to vaccine options.\nWill this latest news shake things up for the struggling pharma company?\nOCU400: A Silver Lining for Struggling OCGN stock\nArguably, OCU400 is Ocugen’s main prize-horse going forward. Anticipation surrounding the company’s breakthrough gene-therapy programs has taken OCGN stock to the moon and back in the past few years. However, that anticipation has largely died down. With many estimating it could be years before such a therapy hits the market, combined with seemingly constant roadblocks for its vaccine candidate, OCGN stock has been on a cold streak for quite a while. Therefore, this news should come as a breath of fresh air for OCGN investors.\nPreliminary estimates see OCU400 being a completely novel solution to a series of retinal degenerative diseases. This year, the European Medicines Agency (EMA) even granted OCU400 a broad medical designation for two different optical diseases.\nWhile investors currently seem hesitant, hope isn’t lost yet. Positive developments of this nature can create the positive momentum necessary to bring the stock back from the dead.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":1890,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603113779,"gmtCreate":1638372713520,"gmtModify":1638372713685,"author":{"id":"3581601922547073","authorId":"3581601922547073","name":"JJSLIN","avatar":"https://static.tigerbbs.com/bcd611a21236602bc49267fe3296259e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581601922547073","authorIdStr":"3581601922547073"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>🚀🚀🚀","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>🚀🚀🚀","text":"$Histogenics(OCGN)$🚀🚀🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603113779","isVote":1,"tweetType":1,"viewCount":2087,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600429819,"gmtCreate":1638190098563,"gmtModify":1638190098719,"author":{"id":"3581601922547073","authorId":"3581601922547073","name":"JJSLIN","avatar":"https://static.tigerbbs.com/bcd611a21236602bc49267fe3296259e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581601922547073","authorIdStr":"3581601922547073"},"themes":[],"htmlText":"End day become infinity 😀","listText":"End day become infinity 😀","text":"End day become infinity 😀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600429819","repostId":"600463556","repostType":1,"repost":{"id":600463556,"gmtCreate":1638189041072,"gmtModify":1638189041072,"author":{"id":"9000000000000198","authorId":"9000000000000198","name":"JuanJohnson","avatar":"https://static.tigerbbs.com/11f0390f4344fa15e794478b64ee460f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000198","authorIdStr":"9000000000000198"},"themes":[],"htmlText":"Imagine now you would have to take 4 booster shots a year for life. Two for delta, two for omicron... And guess what? Next year you can add 4 more for another two variants that come along!Covaxin is good for all corona virus'<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>","listText":"Imagine now you would have to take 4 booster shots a year for life. Two for delta, two for omicron... And guess what? Next year you can add 4 more for another two variants that come along!Covaxin is good for all corona virus'<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>","text":"Imagine now you would have to take 4 booster shots a year for life. Two for delta, two for omicron... And guess what? Next year you can add 4 more for another two variants that come along!Covaxin is good for all corona virus'$Histogenics(OCGN)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600463556","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2158,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877605122,"gmtCreate":1637919833671,"gmtModify":1637919833721,"author":{"id":"3581601922547073","authorId":"3581601922547073","name":"JJSLIN","avatar":"https://static.tigerbbs.com/bcd611a21236602bc49267fe3296259e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581601922547073","authorIdStr":"3581601922547073"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>🚀🌙 💎🙌💎","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>🚀🌙 💎🙌💎","text":"$Histogenics(OCGN)$🚀🌙 💎🙌💎","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877605122","isVote":1,"tweetType":1,"viewCount":1949,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844946450,"gmtCreate":1636385029144,"gmtModify":1636385041175,"author":{"id":"3581601922547073","authorId":"3581601922547073","name":"JJSLIN","avatar":"https://static.tigerbbs.com/bcd611a21236602bc49267fe3296259e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581601922547073","authorIdStr":"3581601922547073"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Drop till I no feeling already.The best you can drop till $1 & let’s us ready for this roller coaster ride 🚀🚀🚀🚀🚀🚀","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Drop till I no feeling already.The best you can drop till $1 & let’s us ready for this roller coaster ride 🚀🚀🚀🚀🚀🚀","text":"$Histogenics(OCGN)$Drop till I no feeling already.The best you can drop till $1 & let’s us ready for this roller coaster ride 🚀🚀🚀🚀🚀🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844946450","isVote":1,"tweetType":1,"viewCount":1893,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":131408582,"gmtCreate":1621870841346,"gmtModify":1631889372722,"author":{"id":"3581601922547073","authorId":"3581601922547073","name":"JJSLIN","avatar":"https://static.tigerbbs.com/bcd611a21236602bc49267fe3296259e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581601922547073","authorIdStr":"3581601922547073"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ETHE\">$Grayscale Ethereum Trust(ETHE)$</a>Show Us Your Miracle","listText":"<a href=\"https://laohu8.com/S/ETHE\">$Grayscale Ethereum Trust(ETHE)$</a>Show Us Your Miracle","text":"$Grayscale Ethereum Trust(ETHE)$Show Us Your Miracle","images":[{"img":"https://static.tigerbbs.com/a8618146c60ff323395f52e7692be4c2","width":"1440","height":"3200"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/131408582","isVote":1,"tweetType":1,"viewCount":1022,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":103934635,"gmtCreate":1619742458927,"gmtModify":1634210294637,"author":{"id":"3581601922547073","authorId":"3581601922547073","name":"JJSLIN","avatar":"https://static.tigerbbs.com/bcd611a21236602bc49267fe3296259e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581601922547073","authorIdStr":"3581601922547073"},"themes":[],"htmlText":"Thanks ","listText":"Thanks ","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/103934635","repostId":"2131534297","repostType":4,"isVote":1,"tweetType":1,"viewCount":1827,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":347437100,"gmtCreate":1618516395800,"gmtModify":1634292419920,"author":{"id":"3581601922547073","authorId":"3581601922547073","name":"JJSLIN","avatar":"https://static.tigerbbs.com/bcd611a21236602bc49267fe3296259e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581601922547073","authorIdStr":"3581601922547073"},"themes":[],"htmlText":"Let's earn more money ","listText":"Let's earn more money ","text":"Let's earn more money","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/347437100","repostId":"1153108819","repostType":4,"isVote":1,"tweetType":1,"viewCount":1924,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":347434748,"gmtCreate":1618516292784,"gmtModify":1634292420141,"author":{"id":"3581601922547073","authorId":"3581601922547073","name":"JJSLIN","avatar":"https://static.tigerbbs.com/bcd611a21236602bc49267fe3296259e","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581601922547073","authorIdStr":"3581601922547073"},"themes":[],"htmlText":"3.51","listText":"3.51","text":"3.51","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/347434748","repostId":"1181372898","repostType":4,"isVote":1,"tweetType":1,"viewCount":952,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}